LEBRIKIZUMAB-LBKZ

LEBRIKIZUMAB-LBKZ was reported 2280 times

LEBRIKIZUMAB-LBKZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THIRD TRIMESTER PREGNANCY 1 0.1250
1 ANORECTAL INFECTION BACTERIAL 1 0.0667
2 EYELID DISCOLOURATION 2 0.0392
3 RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR 1 0.0385
4 ANAL PARAESTHESIA 1 0.0345
5 MALIGNANT HISTIOCYTOSIS 1 0.0323
6 ADMINISTRATION SITE URTICARIA 1 0.0312
7 VIRAL TITRE DECREASED 1 0.0278
8 OCULAR MELANOMA 1 0.0161
9 COINFECTION 1 0.0145
10 PERIORBITAL DERMATITIS 1 0.0128
11 SWELLING OF NOSE 2 0.0116
12 RABIES 1 0.0110
13 MALIGNANT MELANOMA STAGE 0 2 0.0096
14 CAROTID ARTERY STENT INSERTION 1 0.0093
15 IMPLANT SITE HYPERSENSITIVITY 1 0.0090
16 OPTIC DISC OEDEMA 1 0.0086
17 CONJUNCTIVITIS 154 0.0083
18 SUBCORNEAL PUSTULAR DERMATOSIS 1 0.0081
19 CUTANEOUS T-CELL LYMPHOMA 10 0.0079
20 LARYNGEAL DYSKINESIA 1 0.0078
21 PH BODY FLUID ABNORMAL 1 0.0072
22 INJECTION SITE DERMATITIS 1 0.0069
23 ENTEROBIASIS 1 0.0067
24 PERIPANCREATIC FLUID COLLECTION 1 0.0066
25 PERIORAL DERMATITIS 4 0.0063
26 SCROTAL ERYTHEMA 1 0.0060
27 INJECTION SITE EXFOLIATION 4 0.0060
28 PROSTATIC OBSTRUCTION 1 0.0060
29 RENAL EMBOLISM 1 0.0054
30 ECZEMA EYELIDS 3 0.0054
31 KERATOCONUS 2 0.0053
32 METASTASES TO SPINAL CORD 1 0.0052
33 TOPICAL STEROID WITHDRAWAL REACTION 2 0.0051
34 UROGENITAL DISORDER 1 0.0050
35 LEPROSY 1 0.0048
36 ECZEMA HERPETICUM 2 0.0043
37 HELMINTHIC INFECTION 1 0.0041
38 PARAPSORIASIS 1 0.0037
39 PUTAMEN HAEMORRHAGE 1 0.0035
40 GENERALISED PUSTULAR PSORIASIS 1 0.0034
41 GENITAL PARAESTHESIA 1 0.0034
42 TRANSIENT ACANTHOLYTIC DERMATOSIS 1 0.0034
43 PHARYNGEAL OPERATION 1 0.0031
44 VITILIGO 7 0.0030
45 DERMATITIS ATOPIC 149 0.0028
46 EYELID MARGIN CRUSTING 8 0.0028
47 ECZEMA 135 0.0026
48 ANHIDROSIS 1 0.0025
49 VIRAL RASH 1 0.0025
50 EYELID IRRITATION 6 0.0024
51 PERIORBITAL PAIN 2 0.0024
52 SEXUALLY TRANSMITTED DISEASE 1 0.0023
53 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
54 EYELIDS PRURITUS 7 0.0022
55 INJECTION SITE DRYNESS 2 0.0022
56 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
57 MATERNAL EXPOSURE TIMING UNSPECIFIED 8 0.0021
58 EYELID RASH 2 0.0020
59 REBOUND ATOPIC DERMATITIS 4 0.0020
60 KERATITIS 6 0.0020
61 INJECTION SITE PARAESTHESIA 3 0.0020
62 REBOUND ECZEMA 4 0.0020
63 EYE ALLERGY 3 0.0019
64 INCORRECT DOSE ADMINISTERED BY DEVICE 50 0.0019
65 PALMOPLANTAR PUSTULOSIS 1 0.0019
66 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
67 EYE INFECTION BACTERIAL 1 0.0018
68 EYE ULCER 1 0.0017
69 SKIN HYPOPIGMENTATION 3 0.0017
70 PUSTULE 4 0.0017
71 EYELID SKIN DRYNESS 2 0.0016
72 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 28 0.0016
73 NEURODERMATITIS 6 0.0016
74 DERMATOSIS 1 0.0016
75 INJECTION SITE LACERATION 1 0.0016
76 EYE PRURITUS 52 0.0015
77 NASAL CRUSTING 1 0.0015
78 DERMATITIS PSORIASIFORM 3 0.0015
79 CYTOKINE STORM 1 0.0015
80 OPHTHALMIC MIGRAINE 1 0.0014
81 SKIN FISSURES 28 0.0014
82 DYSHIDROTIC ECZEMA 1 0.0014
83 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
84 CONJUNCTIVITIS ALLERGIC 2 0.0013
85 BLISTER RUPTURE 1 0.0013
86 OVARIAN NEOPLASM 1 0.0013
87 OCULAR HYPERAEMIA 62 0.0013
88 ERYTHEMA OF EYELID 7 0.0013
89 INFECTION PARASITIC 1 0.0013
90 SWELLING OF EYELID 8 0.0013
91 GROWTH OF EYELASHES 1 0.0013
92 PNEUMONIA MYCOPLASMAL 1 0.0013
93 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
94 EYE DISCHARGE 13 0.0012
95 HERPES ZOSTER DISSEMINATED 1 0.0012
96 SKIN BACTERIAL INFECTION 1 0.0012
97 ACNE PUSTULAR 1 0.0012
98 SENSITIVE SKIN 9 0.0012
99 INJECTION SITE COLDNESS 1 0.0012
100 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
101 ABDOMINAL LYMPHADENOPATHY 1 0.0012
102 SKIN WEEPING 4 0.0011
103 MUSCLE SWELLING 1 0.0011
104 PRURIGO 1 0.0011
105 ROSACEA 5 0.0011
106 FOREIGN BODY IN EYE 1 0.0010
107 BLEPHARITIS 4 0.0010
108 EYELID PAIN 2 0.0010
109 EYE COLOUR CHANGE 1 0.0010
110 INJECTION SITE DISCOMFORT 10 0.0009
111 NEUROMYOPATHY 1 0.0009
112 HALO VISION 1 0.0009
113 SKIN HAEMORRHAGE 13 0.0009
114 LACRIMATION INCREASED 26 0.0009
115 SKIN WARM 5 0.0009
116 INJECTION SITE URTICARIA 21 0.0009
117 INJECTION SITE PAIN 260 0.0008
118 DERMATITIS 17 0.0008
119 EYE IRRITATION 45 0.0008
120 HERPES SIMPLEX 5 0.0008
121 NAIL DISCOLOURATION 3 0.0008
122 HERPES OPHTHALMIC 1 0.0008
123 LIP EXFOLIATION 1 0.0008
124 SKIN DISCOMFORT 2 0.0007
125 SKIN EXFOLIATION 62 0.0007
126 EYE INFLAMMATION 7 0.0007
127 SKIN DEPIGMENTATION 1 0.0007
128 EYE DISORDER 24 0.0007
129 CORNEAL ABRASION 1 0.0007
130 RASH MORBILLIFORM 2 0.0007
131 ORAL HERPES 14 0.0007
132 JOINT INSTABILITY 1 0.0007
133 THERAPEUTIC RESPONSE DELAYED 2 0.0007
134 EYE INFECTION 8 0.0007
135 PERIORBITAL SWELLING 4 0.0007
136 MENINGITIS BACTERIAL 1 0.0007
137 INJECTION SITE HYPOAESTHESIA 1 0.0007
138 CHAPPED LIPS 3 0.0007
139 PRURITUS 264 0.0007
140 DRY EYE 34 0.0007
141 EYE SWELLING 25 0.0007
142 IMPETIGO 1 0.0007
143 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
144 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
145 ORAL MUCOSAL ERUPTION 1 0.0007
146 MYELITIS 1 0.0006
147 INJECTION SITE HYPERSENSITIVITY 2 0.0006
148 SKIN TIGHTNESS 3 0.0006
149 SKIN ABRASION 3 0.0006
150 TESTICULAR PAIN 2 0.0006
151 NASAL ULCER 1 0.0006
152 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
153 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
154 OCULAR DISCOMFORT 7 0.0006
155 SKIN EROSION 2 0.0006
156 INJECTION RELATED REACTION 1 0.0006
157 EOSINOPHIL COUNT INCREASED 5 0.0006
158 DRY SKIN 79 0.0006
159 CEREBELLAR INFARCTION 1 0.0006
160 MILIARIA 1 0.0006
161 SPINAL CORD INJURY 1 0.0006
162 EXTREMITY NECROSIS 1 0.0006
163 SPLENIC INFARCTION 1 0.0006
164 ALOPECIA AREATA 1 0.0006
165 THERAPEUTIC RESPONSE DECREASED 34 0.0006
166 OPHTHALMIC HERPES ZOSTER 1 0.0006
167 SEBORRHOEA 2 0.0005
168 INJECTION SITE INJURY 3 0.0005
169 HYPERTRICHOSIS 1 0.0005
170 ERYTHEMA 109 0.0005
171 NARCOLEPSY 1 0.0005
172 PRODUCT STORAGE ISSUE 2 0.0005
173 HERPES VIRUS INFECTION 3 0.0005
174 ANAPHYLACTOID REACTION 2 0.0005
175 CHEST INJURY 1 0.0005
176 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
177 SKIN INDURATION 1 0.0005
178 ANAL PRURITUS 1 0.0005
179 BLEPHAROSPASM 3 0.0005
180 SLEEP DEFICIT 1 0.0005
181 INJECTION SITE SWELLING 36 0.0005
182 PRODUCT DISPENSING ISSUE 2 0.0005
183 SKIN HYPERPIGMENTATION 4 0.0005
184 EXOPHTHALMOS 1 0.0005
185 HORDEOLUM 2 0.0005
186 INJECTION SITE INDENTATION 1 0.0005
187 SKIN SWELLING 4 0.0005
188 IMMUNOSUPPRESSION 4 0.0005
189 DANDRUFF 1 0.0005
190 INJECTION SITE REACTION 31 0.0005
191 INFECTIOUS MONONUCLEOSIS 1 0.0004
192 METASTASES TO MENINGES 1 0.0004
193 INJECTION SITE HAEMORRHAGE 35 0.0004
194 LICHEN PLANUS 1 0.0004
195 RASH MACULAR 15 0.0004
196 INJECTION SITE RASH 13 0.0004
197 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
198 VARICELLA 1 0.0004
199 BREATH ODOUR 1 0.0004
200 RASH 178 0.0004
201 DERMAL CYST 1 0.0004
202 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
203 INJECTION SITE PRURITUS 27 0.0004
204 INJECTION SITE INFLAMMATION 2 0.0004
205 RASH ERYTHEMATOUS 19 0.0004
206 VASODILATATION 1 0.0004
207 SKIN BURNING SENSATION 28 0.0004
208 INJECTION SITE INDURATION 5 0.0004
209 SENSITIVITY TO WEATHER CHANGE 2 0.0004
210 EXFOLIATIVE RASH 1 0.0004
211 SCRATCH 4 0.0004
212 COMPRESSION FRACTURE 2 0.0004
213 INJECTION SITE DISCHARGE 2 0.0004
214 INJECTION SITE ERYTHEMA 46 0.0004
215 ULCERATIVE KERATITIS 1 0.0004
216 URTICARIA 61 0.0004
217 INJECTION SITE NODULE 4 0.0004
218 MACULE 1 0.0004
219 ELECTRIC SHOCK SENSATION 1 0.0004
220 SKIN HYPERTROPHY 1 0.0004
221 EYE PAIN 20 0.0004
222 INJECTION SITE SCAR 1 0.0004
223 PHARYNGEAL DISORDER 1 0.0003
224 ABORTION 1 0.0003
225 UNDERDOSE 25 0.0003
226 STRABISMUS 1 0.0003
227 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
228 IRITIS 1 0.0003
229 SKIN LESION 9 0.0003
230 BURNING SENSATION 23 0.0003
231 RETINAL DETACHMENT 3 0.0003
232 PIGMENTATION DISORDER 2 0.0003
233 PHOTOPHOBIA 6 0.0003
234 THERAPEUTIC RESPONSE CHANGED 2 0.0003
235 INCORRECT DOSE ADMINISTERED 72 0.0003
236 INJECTION SITE IRRITATION 4 0.0003
237 FOREIGN BODY SENSATION IN EYES 2 0.0003
238 EXPOSURE VIA SKIN CONTACT 8 0.0003
239 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
240 PHARYNGEAL SWELLING 3 0.0003
241 INJECTION SITE INFECTION 1 0.0003
242 SKIN DISORDER 10 0.0003
243 PAIN OF SKIN 8 0.0003
244 HEPATIC CYST 1 0.0003
245 B-CELL LYMPHOMA 1 0.0003
246 INJECTION SITE WARMTH 6 0.0003
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
248 FORMICATION 2 0.0003
249 CONJUNCTIVAL HYPERAEMIA 1 0.0003
250 HERPES ZOSTER 16 0.0003
251 PHARYNGITIS STREPTOCOCCAL 3 0.0003
252 SKIN LACERATION 3 0.0003
253 RASH PUSTULAR 2 0.0003
254 CUTANEOUS VASCULITIS 1 0.0003
255 INJECTION SITE MASS 10 0.0003
256 ARTHROPOD BITE 2 0.0003
257 SUNBURN 2 0.0003
258 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
259 CLAVICLE FRACTURE 1 0.0003
260 FOOD ALLERGY 2 0.0003
261 CONCUSSION 2 0.0003
262 RASH PRURITIC 14 0.0003
263 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
264 HYPERSENSITIVITY 47 0.0003
265 RHINITIS 2 0.0002
266 FUNGAL SKIN INFECTION 1 0.0002
267 VISION BLURRED 34 0.0002
268 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
269 PERIPHERAL VENOUS DISEASE 1 0.0002
270 THERAPY NON-RESPONDER 11 0.0002
271 HYPERURICAEMIA 1 0.0002
272 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
273 SECRETION DISCHARGE 3 0.0002
274 DERMATITIS ALLERGIC 3 0.0002
275 INJECTION SITE BRUISING 19 0.0002
276 SKIN PLAQUE 2 0.0002
277 GINGIVAL SWELLING 1 0.0002
278 EYE HAEMORRHAGE 3 0.0002
279 FACIAL PAIN 2 0.0002
280 RASH PAPULAR 5 0.0002
281 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
282 OPTIC NEURITIS 2 0.0002
283 INJECTION SITE PAPULE 1 0.0002
284 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
285 LUMBAR VERTEBRAL FRACTURE 1 0.0002
286 SKIN DISCOLOURATION 10 0.0002
287 EYE OPERATION 1 0.0002
288 SYNOVIAL CYST 1 0.0002
289 ORAL DISCOMFORT 3 0.0002
290 FEELING OF DESPAIR 1 0.0002
291 RASH VESICULAR 1 0.0002
292 GUILLAIN-BARRE SYNDROME 1 0.0002
293 RENAL CELL CARCINOMA 1 0.0002
294 DRUG DOSE OMISSION BY DEVICE 16 0.0002
295 THERAPY CHANGE 2 0.0002
296 VISUAL IMPAIRMENT 25 0.0002
297 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
298 VULVOVAGINAL PRURITUS 1 0.0002
299 EYELID PTOSIS 2 0.0002
300 ENDOCARDITIS 1 0.0002
301 PERIPHERAL VASCULAR DISORDER 1 0.0002
302 APLASTIC ANAEMIA 1 0.0002
303 BRAIN FOG 3 0.0002
304 OVERWEIGHT 1 0.0002
305 HYPOACUSIS 8 0.0002
306 GINGIVITIS 1 0.0002
307 CONDITION AGGRAVATED 56 0.0002
308 DRUG INEFFECTIVE 241 0.0002
309 NONSPECIFIC REACTION 1 0.0002
310 TREATMENT FAILURE 15 0.0002
311 STREPTOCOCCAL INFECTION 1 0.0002
312 PRODUCT LEAKAGE 1 0.0002
313 SCAB 2 0.0002
314 SKIN IRRITATION 8 0.0002
315 MUSCULOSKELETAL DISCOMFORT 3 0.0002
316 SKIN ATROPHY 1 0.0002
317 VASCULITIS 2 0.0002
318 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
319 SLEEP DISORDER 12 0.0002
320 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
321 SYMPTOM RECURRENCE 1 0.0002
322 INJECTION SITE VESICLES 1 0.0002
323 DISCOMFORT 10 0.0002
324 MENISCUS INJURY 1 0.0002
325 TENDON RUPTURE 2 0.0002
326 SCOLIOSIS 1 0.0002
327 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
328 NASAL DRYNESS 1 0.0002
329 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
330 GLAUCOMA 3 0.0002
331 CARDIAC FLUTTER 1 0.0002
332 SWELLING FACE 10 0.0002
333 PSORIASIS 20 0.0002
334 PRODUCT PREPARATION ISSUE 1 0.0002
335 STAPHYLOCOCCAL INFECTION 5 0.0002
336 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
337 CARDIAC FAILURE ACUTE 1 0.0001
338 SKIN MASS 1 0.0001
339 TERMINAL STATE 1 0.0001
340 WRONG PRODUCT ADMINISTERED 1 0.0001
341 FEEDING DISORDER 3 0.0001
342 UVEITIS 2 0.0001
343 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
344 EYE MOVEMENT DISORDER 1 0.0001
345 RESPIRATION ABNORMAL 1 0.0001
346 BLISTER 8 0.0001
347 SKIN REACTION 2 0.0001
348 PAPULE 1 0.0001
349 SEASONAL ALLERGY 2 0.0001
350 HAND FRACTURE 1 0.0001
351 FEAR OF INJECTION 1 0.0001
352 VISUAL FIELD DEFECT 1 0.0001
353 TONGUE DISORDER 1 0.0001
354 DERMATITIS BULLOUS 1 0.0001
355 ILLNESS 14 0.0001
356 SNEEZING 3 0.0001
357 ASTHMA 15 0.0001
358 PEMPHIGOID 1 0.0001
359 THYROID DISORDER 2 0.0001
360 TENDONITIS 2 0.0001
361 APHTHOUS ULCER 1 0.0001
362 APNOEA 1 0.0001
363 ANAPHYLACTIC REACTION 7 0.0001
364 FURUNCLE 1 0.0001
365 NASAL DISCOMFORT 1 0.0001
366 PRODUCT PRESCRIBING ERROR 3 0.0001
367 RENAL CYST 1 0.0001
368 HIP FRACTURE 4 0.0001
369 MUSCLE TIGHTNESS 2 0.0001
370 PRESYNCOPE 3 0.0001
371 BLINDNESS 5 0.0001
372 ARTHRALGIA 51 0.0001
373 PHOTOSENSITIVITY REACTION 2 0.0001
374 HEMIPLEGIA 1 0.0001
375 VITAMIN D DECREASED 1 0.0001
376 SCAR 2 0.0001
377 CARDIAC OPERATION 1 0.0001
378 DIPLOPIA 3 0.0001
379 HYSTERECTOMY 1 0.0001
380 MENTAL DISORDER 5 0.0001
381 EOSINOPHILIA 2 0.0001
382 GRIP STRENGTH DECREASED 1 0.0001
383 PRODUCT COMMUNICATION ISSUE 1 0.0001
384 LYMPHADENOPATHY 4 0.0001
385 DRUG ERUPTION 2 0.0001
386 THIRST 2 0.0001
387 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
388 GASTROINTESTINAL INFECTION 1 0.0001
389 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
390 GASTROENTERITIS VIRAL 2 0.0001
391 OROPHARYNGEAL DISCOMFORT 1 0.0001
392 HIDRADENITIS 1 0.0001
393 BRAIN NEOPLASM 1 0.0001
394 INCREASED TENDENCY TO BRUISE 1 0.0001
395 DEMENTIA 3 0.0001
396 WOUND 3 0.0001
397 MIDDLE INSOMNIA 2 0.0001
398 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
399 SQUAMOUS CELL CARCINOMA 1 0.0001
400 FOOT FRACTURE 2 0.0001
401 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
402 PRESCRIBED OVERDOSE 2 0.0001
403 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
404 VITREOUS FLOATERS 1 0.0001
405 LIGAMENT SPRAIN 1 0.0001
406 SINUS DISORDER 2 0.0001
407 BRAIN INJURY 1 0.0001
408 TOXIC SKIN ERUPTION 1 0.0001
409 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
410 DRY THROAT 1 0.0001
411 INJURY ASSOCIATED WITH DEVICE 2 0.0001
412 EAR DISCOMFORT 1 0.0001
413 INFLAMMATION 5 0.0001
414 ALOPECIA 19 0.0001
415 TENDERNESS 1 0.0001
416 PETECHIAE 1 0.0001
417 NERVOUSNESS 5 0.0001
418 FOLLICULITIS 1 0.0001
419 PARAESTHESIA 15 0.0001
420 BREAST PAIN 1 0.0001
421 BODY HEIGHT DECREASED 1 0.0001
422 SKIN CANCER 2 0.0001
423 MENSTRUATION DELAYED 1 0.0001
424 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
425 EXPIRED PRODUCT ADMINISTERED 3 0.0001
426 NERVE INJURY 1 0.0001
427 RASH MACULO-PAPULAR 2 0.0001
428 NEOPLASM MALIGNANT 6 0.0001
429 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
430 REBOUND EFFECT 1 0.0001
431 DERMATITIS CONTACT 1 0.0001
432 MADAROSIS 1 0.0001
433 ELECTROLYTE IMBALANCE 1 0.0001
434 NASAL CONGESTION 5 0.0001
435 WRIST FRACTURE 1 0.0001
436 LOCALISED INFECTION 2 0.0001
437 ACCIDENTAL OVERDOSE 3 0.0001
438 NASOPHARYNGITIS 15 0.0001
439 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
440 AGEUSIA 2 0.0001
441 INJECTION SITE DISCOLOURATION 1 0.0001
442 ACNE 6 0.0001
443 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
444 RHINORRHOEA 5 0.0001
445 HAND DEFORMITY 1 0.0001
446 IMMUNE SYSTEM DISORDER 1 0.0001
447 SARS-COV-2 TEST POSITIVE 1 0.0001
448 OROPHARYNGEAL PAIN 7 0.0001
449 ADVERSE REACTION 1 0.0001
450 SWELLING 7 0.0001
451 JOINT SWELLING 9 0.0001
452 CONTUSION 7 0.0001
453 PROCEDURAL PAIN 2 0.0001
454 INFLUENZA 8 0.0001
455 APHONIA 1 0.0001
456 NECK PAIN 4 0.0001
457 MASS 1 0.0001
458 BLINDNESS UNILATERAL 1 0.0001
459 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
460 INTENTIONAL DOSE OMISSION 2 0.0001
461 THERAPY INTERRUPTED 5 0.0001
462 HYPOKINESIA 1 0.0001
463 FLUSHING 7 0.0001
464 URINARY INCONTINENCE 2 0.0001
465 HOT FLUSH 5 0.0001
466 VERTIGO 4 0.0001
467 DIABETES MELLITUS 5 0.0001
468 LIMB DISCOMFORT 2 0.0001
469 INSOMNIA 17 0.0001
470 HEAD INJURY 2 0.0001
471 PNEUMOTHORAX 1 0.0001
472 ULCER 1 0.0001
473 MIGRAINE 6 0.0001
474 OBESITY 1 0.0001
475 ABSCESS 1 0.0001
476 SENSORY DISTURBANCE 1 0.0001
477 DRUG INTOLERANCE 6 0.0001
478 NIGHT SWEATS 2 0.0001
479 VIRAL INFECTION 2 0.0001
480 LIP SWELLING 2 0.0001
481 CHILLS 7 0.0001
482 FACE OEDEMA 1 0.0001
483 THERAPY CESSATION 3 0.0001
484 FEELING ABNORMAL 14 0.0001
485 ABDOMINAL PAIN UPPER 12 0.0001
486 DEVICE USE ISSUE 1 0.0001
487 AMENORRHOEA 1 0.0001
488 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
489 GOUT 1 0.0001
490 OVERDOSE 12 0.0001
491 SYNOVITIS 1 0.0001
492 TOOTHACHE 1 0.0001
493 PELVIC PAIN 1 0.0001
494 BONE DISORDER 1 0.0001
495 MUSCLE SPASMS 10 0.0001
496 HEADACHE 34 0.0001
497 THINKING ABNORMAL 1 0.0001
498 BACTERIAL INFECTION 1 0.0001
499 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
500 BLOOD SODIUM DECREASED 1 0.0001
501 MYALGIA 9 0.0001
502 ANXIETY 15 0.0001
503 MUSCULOSKELETAL DISORDER 1 0.0001
504 INCREASED APPETITE 1 0.0001
505 PULMONARY FIBROSIS 1 0.0001
506 LOWER LIMB FRACTURE 1 0.0001
507 EAR PAIN 1 0.0001
508 BONE PAIN 3 0.0001
509 KIDNEY INFECTION 1 0.0001
510 ABORTION SPONTANEOUS 2 0.0000
511 FULL BLOOD COUNT DECREASED 1 0.0000
512 OFF LABEL USE 43 0.0000
513 CHEST DISCOMFORT 5 0.0000
514 SINUSITIS 5 0.0000
515 PRODUCT PREPARATION ERROR 1 0.0000
516 INFECTION 7 0.0000
517 TOOTH LOSS 1 0.0000
518 ABDOMINAL DISTENSION 5 0.0000
519 MOUTH ULCERATION 1 0.0000
520 RETCHING 1 0.0000
521 HYPOAESTHESIA 7 0.0000
522 IRRITABLE BOWEL SYNDROME 1 0.0000
523 LIVER FUNCTION TEST INCREASED 1 0.0000
524 HYPERHIDROSIS 6 0.0000
525 POOR QUALITY SLEEP 1 0.0000
526 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
527 DIZZINESS 23 0.0000
528 PRODUCT DISPENSING ERROR 1 0.0000
529 MUSCULOSKELETAL STIFFNESS 4 0.0000
530 PAIN 28 0.0000
531 PERIPHERAL SWELLING 7 0.0000
532 ORAL PAIN 1 0.0000
533 THROAT IRRITATION 2 0.0000
534 PANCREATITIS ACUTE 1 0.0000
535 CHROMATURIA 1 0.0000
536 MUSCULAR WEAKNESS 5 0.0000
537 BACK PAIN 10 0.0000
538 COUGH 12 0.0000
539 PALPITATIONS 5 0.0000
540 MENTAL IMPAIRMENT 1 0.0000
541 NEURALGIA 1 0.0000
542 PRODUCT DOSE OMISSION ISSUE 12 0.0000
543 CELLULITIS 2 0.0000
544 HOSPITALISATION 6 0.0000
545 SKIN ULCER 1 0.0000
546 RESPIRATORY TRACT INFECTION 1 0.0000
547 HAEMORRHAGE 4 0.0000
548 DEAFNESS 1 0.0000
549 ARTHRITIS 3 0.0000
550 GASTRITIS 1 0.0000
551 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
552 DEHYDRATION 5 0.0000
553 LIMB INJURY 1 0.0000
554 MOOD ALTERED 1 0.0000
555 INFLUENZA LIKE ILLNESS 3 0.0000
556 RESPIRATORY DISTRESS 1 0.0000
557 ABNORMAL DREAMS 1 0.0000
558 FLATULENCE 2 0.0000
559 URINARY TRACT INFECTION 6 0.0000
560 RED BLOOD CELL COUNT DECREASED 1 0.0000
561 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
562 ABDOMINAL PAIN 8 0.0000
563 INTENTIONAL PRODUCT MISUSE 3 0.0000
564 DYSPHONIA 2 0.0000
565 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
566 WHEEZING 2 0.0000
567 OESOPHAGEAL CARCINOMA 1 0.0000
568 CATARACT 2 0.0000
569 GASTROINTESTINAL DISORDER 3 0.0000
570 RESPIRATORY DISORDER 1 0.0000
571 FATIGUE 26 0.0000
572 IRRITABILITY 2 0.0000
573 BLOOD POTASSIUM DECREASED 1 0.0000
574 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
575 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
576 FEMUR FRACTURE 1 0.0000
577 EXPOSURE DURING PREGNANCY 2 0.0000
578 CARDIAC DISORDER 3 0.0000
579 NERVOUS SYSTEM DISORDER 1 0.0000
580 SWOLLEN TONGUE 1 0.0000
581 MALAISE 14 0.0000
582 DYSPNOEA 18 0.0000
583 GAIT DISTURBANCE 6 0.0000
584 MOVEMENT DISORDER 1 0.0000
585 ATRIAL FIBRILLATION 3 0.0000
586 DEEP VEIN THROMBOSIS 2 0.0000
587 DEPRESSION 7 0.0000
588 NAUSEA 24 0.0000
589 HEART RATE INCREASED 3 0.0000
590 FALL 10 0.0000
591 SYNCOPE 3 0.0000
592 ABDOMINAL DISCOMFORT 5 0.0000
593 DIARRHOEA 19 0.0000
594 HEPATIC ENZYME INCREASED 2 0.0000
595 MEMORY IMPAIRMENT 4 0.0000
596 DELIRIUM 1 0.0000
597 DEVICE USE ERROR 1 0.0000
598 WEIGHT DECREASED 8 0.0000
599 CEREBRAL HAEMORRHAGE 1 0.0000
600 CRYING 1 0.0000
601 C-REACTIVE PROTEIN INCREASED 1 0.0000
602 PAIN IN EXTREMITY 8 0.0000
603 CHEST PAIN 5 0.0000
604 DYSPNOEA EXERTIONAL 1 0.0000
605 BLOOD PRESSURE INCREASED 4 0.0000
606 DECREASED APPETITE 6 0.0000
607 DISORIENTATION 1 0.0000
608 CARDIAC FAILURE 2 0.0000
609 THROMBOSIS 2 0.0000
610 EXTRA DOSE ADMINISTERED 1 0.0000
611 LUNG NEOPLASM MALIGNANT 1 0.0000
612 OSTEOPOROSIS 1 0.0000
613 RHABDOMYOLYSIS 1 0.0000
614 CARDIO-RESPIRATORY ARREST 1 0.0000
615 RENAL IMPAIRMENT 2 0.0000
616 HYPERTENSION 5 0.0000
617 OSTEOARTHRITIS 1 0.0000
618 LOSS OF CONSCIOUSNESS 3 0.0000
619 COVID-19 4 0.0000
620 LIVER DISORDER 1 0.0000
621 TACHYCARDIA 2 0.0000
622 PULMONARY OEDEMA 1 0.0000
623 WEIGHT INCREASED 5 0.0000
624 ADVERSE DRUG REACTION 2 0.0000
625 NEPHROLITHIASIS 1 0.0000
626 BLOOD CHOLESTEROL INCREASED 1 0.0000
627 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
628 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
629 LUNG DISORDER 1 0.0000
630 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
631 VOMITING 9 0.0000
632 MUSCULOSKELETAL PAIN 1 0.0000
633 DEPRESSED MOOD 1 0.0000
634 DISTURBANCE IN ATTENTION 1 0.0000
635 OEDEMA 1 0.0000
636 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
637 ARTHROPATHY 1 0.0000
638 CEREBROVASCULAR ACCIDENT 3 0.0000
639 SURGERY 1 0.0000
640 STOMATITIS 1 0.0000
641 ILL-DEFINED DISORDER 1 0.0000
642 OEDEMA PERIPHERAL 2 0.0000
643 FEELING HOT 1 0.0000
644 DEATH 14 0.0000
645 PNEUMONIA 5 0.0000
646 BLOOD PRESSURE DECREASED 1 0.0000
647 SOMNOLENCE 3 0.0000
648 PYREXIA 5 0.0000
649 INJURY 1 0.0000
650 AGITATION 1 0.0000
651 BRONCHITIS 1 0.0000
652 DYSGEUSIA 1 0.0000
653 UNEVALUABLE EVENT 1 0.0000
654 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
655 CONFUSIONAL STATE 2 0.0000
656 CARDIAC ARREST 1 0.0000
657 TREMOR 2 0.0000
658 BALANCE DISORDER 1 0.0000
659 MYOCARDIAL INFARCTION 2 0.0000
660 DEVICE ISSUE 1 0.0000
661 NO ADVERSE EVENT 2 0.0000
662 SUICIDAL IDEATION 1 0.0000
663 DYSPHAGIA 1 0.0000
664 PULMONARY EMBOLISM 1 0.0000
665 HYPOTENSION 2 0.0000
666 HAEMOGLOBIN DECREASED 1 0.0000
667 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
668 CONSTIPATION 2 0.0000
669 SEPSIS 1 0.0000
670 RHEUMATOID ARTHRITIS 1 0.0000
671 SEIZURE 1 0.0000
672 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
673 EMOTIONAL DISTRESS 1 0.0000
674 ASTHENIA 3 0.0000
675 RENAL FAILURE 1 0.0000
676 ACUTE KIDNEY INJURY 1 0.0000
677 DRUG INTERACTION 1 0.0000
678 BLOOD GLUCOSE INCREASED 1 0.0000
679 ANAEMIA 1 0.0000